Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZAMZ.L Regulatory News (ZAMZ)

  • There is currently no data for ZAMZ

Termination of Convertible Loan Note Facility

6 Feb 2023 07:00

RNS Number : 9488O
Zamaz PLC
06 February 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU, WHICH IS PART OF UNITED KINGDOM DOMESTIC LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

6 February 2023

Zamaz plc

"Zamaz", "the Company" or "the Group"

Termination of Convertible Loan Note Facility

 

Zamaz Plc, the London-based international e-commerce and retail technology aggregator of sustainable brands, announces that it has terminated its convertible loan note facility with Atlas Capital Markets ("Atlas") by mutual agreement.

 

The facility formed part of a transaction between the Company and Atlas, agreed at the time of the Company's Direct Listing on the Main Market of The London Stock Exchange in September 2022. The transaction comprised an equity investment in 35,332,163 ordinary shares and a £15 million convertible loan note facility plus warrants ("Atlas Investment"). The Company has, in agreement with Atlas, now terminated the convertible loan note and associated warrant facility. No notes or warrants were issued under the facility. Atlas has also sold its entire shareholding to a group of interested investors at the subscription price of 10.45 pence per share.

 

Martin Groak, Non-Executive Chairman of Zamaz commented:

"The Atlas investment formed part of Zamaz's capital structure at the time of our direct listing. However, following our successful Admission we believe that the next phase of growth, primarily through acquisition, will be better served using other forms of acquisition finance, including debt and equity security issues. We expect to be able to update the market shortly regarding our next acquisition."

 

For the purposes of UK MAR, the person responsible for arranging release of this announcement on behalf of Zamaz is Martin Groak, Chairman.

 

Enquiries:

Zamaz plc

Martin Groak, Chairman

 

www.zamaz.tech 

c/o Walbrook PR Limited 

Walbrook PR Limited

Paul Vann/Nick Rome/Joe Walker

 

Tel: 020 7933 8780

or 07768 807631 

zamaz@walbrookpr.com

About Zamaz

Zamaz is a technology driven e-commerce business that originates, acquires or licenses, operates and scales small and medium-sized brands with category-winning products on global marketplaces. With ever prolific customer data sources, the advent of turnkey e-commerce website platforms, such as Shopify, and a thriving ecosystem of third-party software integrators, the options available to launch and build brands that can be marketed, sold, and shipped online quickly and globally with limited risk have never been more compelling. Such marketplaces, led by Amazon and eBay, also provide connection to millions of consumers, and have become a first-choice route-to-market for a generation of micro and small and medium-sized enterprise businesses.

 

Zamaz mines and analyses data from such online retail technology platforms which provide significant insights into consumer shopping behaviour and trends and enable the business to deploy, market and sell an optimised portfolio of brands, products, packs and prices aligned with active, real-time consumer needs and demands principally on UK and EU Amazon marketplaces.

About Bella Dispensa

Bella Dispensa, a wholly-owned subsidiary of Zamaz, is an Italian-based online retailer of gourmet Italian food products which operates in one of the fastest growing online sectors, grocery shopping. The extensive relationships that Bella Dispensa enjoys with its niche food suppliers makes it a strong addition to the Zamaz Brand Portfolio and will give Zamaz the opportunity to showcase and sell Bella Dispensa sourced products on its online platform.

Bella Dispensa has already made two acquisitions since Zamaz listed on the Main Market of the London Stock Exchange: Ecocarni, a purveyor of premium quality meats and associated products sourced from Italy and Argentina to both wholesale and retail customers, from its flagship store in Milan and Eccellenze S.r.l. which has a retail store located on Milan's prestigious Corso Venezia, one of the city's most exclusive and elegant avenues, being part of the upscale Quadrilatero della moda shopping district. Recently established in Q4 2021, Eccellenze has grown rapidly, and now offers over 1,000 premium quality food products in-store, including cheese, pasta, wine and oil. Its highly experienced management team has also developed a unique eno-gastronomic "lifestyle shopping experience" for its growing, highly discerning client base.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFFVFFSIEIIV
12
Date   Source Headline
14th Sep 20237:00 amRNSConfirmation of Name Change to Dispensa Group plc
24th Aug 20237:00 amRNSChange of Name, Board Changes & Accounts Update
31st May 20237:00 amRNSHalf-Year Results to 28 February 2023
27th Mar 20237:00 amRNSTrading Update for Bella Dispensa
21st Mar 202312:10 pmRNSResult of reconvened Bondholders' Meeting
9th Mar 20232:00 pmRNSNotice of Adjourned General Meeting
6th Mar 20237:30 amRNSChange of Registered Office & Company Secretary
21st Feb 20239:05 amRNSSecond Price Monitoring Extn
21st Feb 20239:00 amRNSPrice Monitoring Extension
17th Feb 20232:05 pmRNSSecond Price Monitoring Extn
17th Feb 20232:00 pmRNSPrice Monitoring Extension
17th Feb 20237:00 amRNSNotice of Bondholders' General Meeting
13th Feb 20237:08 amRNSSubsidiary Acquisition
6th Feb 20237:00 amRNSTermination of Convertible Loan Note Facility
1st Feb 20237:00 amRNSResult of AGM & Board & Senior Management changes
16th Jan 20234:40 pmRNSSecond Price Monitoring Extn
16th Jan 20234:35 pmRNSPrice Monitoring Extension
16th Jan 20232:05 pmRNSSecond Price Monitoring Extn
16th Jan 20232:00 pmRNSPrice Monitoring Extension
16th Jan 20237:00 amRNSHoldings in Company & Brand Licence Update
10th Jan 20239:05 amRNSSecond Price Monitoring Extn
10th Jan 20239:00 amRNSPrice Monitoring Extension
6th Jan 20237:00 amRNSNotice of AGM & Posting of Annual Report
6th Jan 20237:00 amRNSDirectorate Changes
5th Dec 20222:05 pmRNSSecond Price Monitoring Extn
5th Dec 20222:00 pmRNSPrice Monitoring Extension
5th Dec 20227:00 amRNS2022 Final Audited Results
2nd Dec 20229:05 amRNSSecond Price Monitoring Extn
2nd Dec 20229:00 amRNSPrice Monitoring Extension
30th Nov 202211:05 amRNSSecond Price Monitoring Extn
30th Nov 202211:00 amRNSPrice Monitoring Extension
28th Nov 20229:05 amRNSSecond Price Monitoring Extn
28th Nov 20229:00 amRNSPrice Monitoring Extension
11th Nov 20225:53 pmRNSIssue of Equity & Total Voting Rights
8th Nov 20227:00 amRNSUpdate on Subsidiary Acquisition
8th Nov 20227:00 amRNSMelloLondon Investor Conference
14th Oct 20227:00 amRNSDirectorate Change
13th Oct 20224:41 pmRNSSecond Price Monitoring Extn
13th Oct 20224:35 pmRNSPrice Monitoring Extension
13th Oct 20222:06 pmRNSSecond Price Monitoring Extn
13th Oct 20222:00 pmRNSPrice Monitoring Extension
13th Oct 202211:05 amRNSSecond Price Monitoring Extn
13th Oct 202211:00 amRNSPrice Monitoring Extension
13th Oct 20229:05 amRNSSecond Price Monitoring Extn
13th Oct 20229:00 amRNSPrice Monitoring Extension
10th Oct 20227:00 amRNSSubsidiary Acquisition
7th Oct 20224:41 pmRNSSecond Price Monitoring Extn
7th Oct 20224:35 pmRNSPrice Monitoring Extension
7th Oct 20222:05 pmRNSSecond Price Monitoring Extn
7th Oct 20222:01 pmRNSPrice Monitoring Extension
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.